# Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac

> **NCT07733219** · NA · NOT_YET_RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 59 (estimated)

## Conditions studied

- Ultracentral Pulmonary Tumors
- Lung Cancer (T1 N0 M0 and T2 N0 M0)
- Mediastinal Lymph Node Recurrence From All Types of Primary Cancer
- Pulmonary Node Recurrence From All Types of Primary Cancer

## Interventions

- **RADIATION:** MRI-LINAC radiotherapy

## Key facts

- **NCT ID:** NCT07733219
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2031-11-01
- **Final completion:** 2031-11-01
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2026-07-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07733219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07733219, "Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07733219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*